jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Oct. 03, 2019

April. 16, 2024

jRCTs031190109

Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A (Ascorbic acid for CMT1A)

Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A (Ascorbic acid treatment for childhood CMT 1A)

SHIOHAMA TADASHI

Chiba University Hospital

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, JAPAN

+81-43-226-2144

asuha_hare@chiba-u.jp

SHIOHAMA TADASHI

Chiba University Hospital

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, JAPAN

+81-43-226-2144

asuha_hare@chiba-u.jp

Not Recruiting

Oct. 03, 2019

Oct. 25, 2019
12

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

1. Children under 18 years of age with confirmed PMP22 duplication in genetic testing.
2. Normal data in blood examination.
3. Normal data in urinary analysis.
4. Written informed consent from the patient, or parents in case of children.

1. The patient has already taken daily vitamin treatment.
2. When the investigator or the investigator considers it inappropriate to conduct this study safely.

No limit
18age old not

Both

Charcot-Marie-Tooth disease type 1A

ascorbic acid dayly intake

CMT1A

ascorbic acid

G600

CMT score

Electrophysiological examination, Six minutes walking distance

Chiba University Certified Clinical Research Review Board
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, Japan, Chiba

+81-43-226-7171

prc-jim@chiba-u.jp
Approval

No

none

History of Changes

No Publication date
8 April. 16, 2024 (this page) Changes
7 April. 10, 2024 Detail Changes
6 April. 03, 2024 Detail Changes
5 June. 16, 2022 Detail Changes
4 Aug. 20, 2021 Detail Changes
3 July. 14, 2021 Detail Changes
2 April. 30, 2020 Detail Changes
1 Oct. 03, 2019 Detail